Synergy Pharma Defends Ch. 11 Sale Plan After Objections - Law360

01/02/19

Synergy Pharma Defends Ch. 11 Sale Plan After Objections  Law360

Synergy Pharmaceuticals Inc. is defending its efforts to sell the business to Bausch Health Cos. Inc. in Chapter 11 for approximately $200 million, telling a New ...

[more]